The report that there is clear evidence that the ebola drug remdesivir can help people recover from covid-19 is clearly good news. Remdesivir cut the duration of symptoms from 15 days down to 11 in clinical trial at hospitals around the world.
However, the impact on deaths is not as clear cut. The mortality rate was 8% in people given remdesivir and 11.6% in those given a placebo, but this result was not statistically significant, meaning scientists cannot tell if the difference is real. Source full article: https://www.bbc.co.uk/news/health-52478783